简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-04-12 15:21 Milestone Study Shows Natural Molecule, Urolithin A, Can Improve Muscle Function and Life Expectancy in Mice With Muscle Dystrophy
2021-04-09 23:50 HempFusion's Products Enter Asia Through Alibaba Group’s Tmall Global
2021-04-09 09:58 uAvionix ping200X is the World’s First FAA TSO Certified Drone Transponder
2021-04-08 16:40 Galderma Announces Publication of Phase 2b Trial Results Demonstrating the Rapid and Long-lasting Benefits of Nemolizumab in Clinical Trial Subjects With Uncontrolled Atopic Dermatitis
2021-04-08 14:09 Erbe Elektromedizin to acquire Maxer Endoscopy
2021-04-08 13:11 AcornMed Selects Twist Bioscience Technology to Power Next Generation Precision Medicine Tests
2021-04-08 11:49 IntelliCentrics Examines Why the COVID-19 Vaccination Falls Short of Being a Total Solution
2021-04-07 18:00 Ingevity to highlight benefits of Capa® caprolactone technology for bioplastic and polyurethane applications at Chinaplas 2021
2021-04-07 16:22 Study Investigates the Effects of Ventilatory Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients Using Masimo O3®
2021-04-06 19:31 CoVIg-19 Plasma Alliance Announces Topline Results from NIH-Sponsored Clinical Trial of Investigational COVID-19 Hyperimmune Globulin Medicine
2021-04-06 16:35 City of Hope and Hospital Israelita Albert Einstein Sign Agreement to Advance Cancer Care in Latin America
2021-04-02 15:50 Takeda Hosts Wave 1 Pipeline Market Call
2021-04-02 14:05 World Government Summit Announces an Exceptional Edition for Best Minister Award
2021-04-02 13:54 Patient Safety Movement Foundation Announces Winners of Lewis Blackman Leadership Award
2021-04-02 10:11 Takeda Completes Sale of Its Japan Consumer Health Care Business Unit to Blackstone
2021-04-01 16:37 Xlife Sciences AG (XLS): 2020 Financial Results
2021-04-01 16:25 Kaye Earns Prestigious ISO/IEC 17025:2017 Accreditation in its China Calibration Laboratory
2021-04-01 11:47 Aptorum Group Announces Dosing First Human Subject in a Phase I Clinical Trial of ALS-4, a First-in-Class Small Molecule Drug Designed to Treat Infections caused by Staphylococcus Aureus including Methicillin-resistant Staphylococcus aureus (MRSA)
2021-04-01 10:39 Advanced Sterilization Products Announces Aisha Barry as President
2021-04-01 10:24 Takeda Completes Sale of Select OTC and Non-Core Assets to Orifarm

Business Wire Weibo

Press Releases

Latest Releases